Shanghai Runda Medical Technology Co Ltd
SSE:603108

Watchlist Manager
Shanghai Runda Medical Technology Co Ltd Logo
Shanghai Runda Medical Technology Co Ltd
SSE:603108
Watchlist
Price: 17.39 CNY 0.52% Market Closed
Market Cap: 10.4B CNY
Have any thoughts about
Shanghai Runda Medical Technology Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one Shanghai Runda Medical Technology Co Ltd stock under the Base Case scenario is 38.94 CNY. Compared to the current market price of 17.39 CNY, Shanghai Runda Medical Technology Co Ltd is Undervalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
38.94 CNY
Undervaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.2
P/S
P/S
Price to Sales
1.2
vs History
0
vs Industry
84
Median 3Y
0.9
Median 5Y
0.9
Industry
4.1
Forward
1
More Details
258.6
P/E
P/E
Price to Earnings
258.6
vs History
0
vs Industry
16
Median 3Y
20.4
Median 5Y
19.4
Industry
32.7
Forward
28.2
More Details
13.8
P/OCF
P/OCF
Price to OCF
13.8
vs History
49
vs Industry
42
Median 3Y
13.9
Median 5Y
16.8
Industry
22.1
More Details
15.8
P/FCFE
P/FCFE
Price to FCFE
15.8
vs History
22
vs Industry
25
Median 3Y
15.4
Median 5Y
10.5
Industry
33.6
More Details
2.4
P/B
P/B
Price to Book Value
2.4
vs History
3
vs Industry
51
Median 3Y
2
Median 5Y
2
Industry
2.6
More Details
1.9
EV/S
EV/S
Enterprise Value to Sales
1.9
vs History
0
vs Industry
74
Median 3Y
1.4
Median 5Y
1.4
Industry
3.9
Forward
1.5
More Details
7.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.2
vs History
0
vs Industry
56
Median 3Y
5.1
Median 5Y
5.1
Industry
8.6
More Details
30.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30.1
vs History
0
vs Industry
22
Median 3Y
13.9
Median 5Y
13.6
Industry
18.5
Forward
11
More Details
30.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30.1
vs History
0
vs Industry
27
Median 3Y
13.9
Median 5Y
13.6
Industry
23.7
Forward
16.4
More Details
21
EV/OCF
EV/OCF
Enterprise Value to OCF
21
vs History
52
vs Industry
35
Median 3Y
21.1
Median 5Y
27.3
Industry
21.4
More Details
34.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
34.8
vs History
22
vs Industry
25
Median 3Y
-16.9
Median 5Y
-24.2
Industry
28.8
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
4
vs Industry
63
Median 3Y
1.1
Median 5Y
1.1
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
Shanghai Runda Medical Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Runda Medical Technology Co Ltd
SSE:603108
10.4B CNY 1.2 258.6 30.1 30.1
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.3B USD 2.4 25.8 14.2 21.7
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.3 32.4 40.7
CN
WuXi AppTec Co Ltd
SSE:603259
162B CNY 4.2 20.1 14.6 14.6

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.